GE HealthCare (GEHC) and Stryker (SYK) on Torvanta's measures: GEHC grades higher on 2 of the 4 factor families and SYK on 2.
| GEHC | SYK | |
|---|---|---|
| Value grade | B+ | C+ |
| Growth grade | C | B |
| Profitability grade | n/a | B- |
| Momentum grade | D+ | D- |
| Market value | n/a | $113.0B |
| P/E (trailing) | n/a | 30.5x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $21.0B | $25.8B |
| Revenue growth (y/y) | n/a | +8% |
| Operating margin | 12.6% | 21.4% |
| Return on invested capital | n/a | 11.3% |
| Free-cash-flow yield | 5.6% | 4.2% |
| Total return, 1 year | -5.0% | -19.3% |
| Total return, 3 years | +4.6% | +14.9% |
Full GEHC analysis · Full SYK analysis
GE HealthCare (GEHC) and Stryker (SYK) on Torvanta's measures: GEHC grades higher on 2 of the 4 factor families and SYK on 2. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings GEHC trades at n/a and SYK at 30.5x; their value grades are B+ and C+ against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer